Therapy with interleukin-2 and tumor-derived activated lymphocytes.
Oldham
R K
RK
Biological Therapy Institute, Franklin, Tennessee.
D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2